Stefan M. Gold
Nora Platiel Str. 4
Kassel, HE 34109, Germany
Kassel, HE 34109, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
A longitudinal analysis of quality and longevity of mental health apps indexed in MIND, the largest database.
Journal: World psychiatry : official journal of the World Psychiatric Association (WPA)
Published: May 15, 2026
A Delphi-method-based consensus for clinical domains and assessment of the inflammatory subtype of major depressive disorder from the ASPIRE study.
Journal: Brain, behavior, and immunity
Published: March 27, 2026
Dronabinol for nightmares in post-traumatic stress disorder: a randomized controlled trial.
Journal: Nature medicine
Published: January 31, 2026
Beyond counting clicks: rethinking engagement in digital mental health.
Journal: The British journal of psychiatry : the journal of mental science
Published: November 24, 2025
Anti-inflammatories for depression: challenges and ASPIRations.
Journal: The lancet. Psychiatry
Published: August 27, 2025
Digital lifestyle management application (levidex) for empowerment and health behaviour change in early multiple sclerosis - Results of the randomised controlled POWER@MS1 trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 12, 2025
Symptom trajectories and their predictive factors in psychiatric inpatients with depression.
Journal: Journal of affective disorders
Published: July 26, 2025
The caregiver's journey: A qualitative study on the integration of family caregivers of advanced cancer patients in outpatient settings in Germany.
Journal: Palliative & supportive care
Published: July 08, 2025
Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy.
Journal: Cardiovascular research
Published: July 01, 2025
Factors influencing health behavior changes in people with early multiple sclerosis: process evaluation of the multicenter randomized controlled POWER@MS1 trial.
Journal: Frontiers in neurology
Published: May 27, 2025
Design Considerations for a Phase II Platform Trial in Major Depressive Disorder.
Journal: Pharmaceutical statistics
Published: May 02, 2025
Last Updated: 09/26/2026